hydrogenThyssenkruppWorld News

Thyssenkrupp hydrogen business eyes up to $687 million in IPO proceeds

Investing.com - Financial Markets Worldwide

Please try another search

ReutersStock Markets16 minutes ago (Jan 13, 2022 04:25AM ET)

© Reuters. FILE PHOTO: A logo of Thyssenkrupp AG is pictured at the company’s headquarters in Essen, Germany, November 21, 2018. REUTERS/Thilo Schmuelgen/File Photo

By Christoph Steitz and Tom Käckenhoff

FRANKFURT/DUESSELDORF (Reuters) -Thyssenkrupp’s electrolysis business is aiming for proceeds of up to 600 million euros ($687 million) by selling new shares in a possible initial public offering this year, betting on the booming hydrogen sector it supplies with equipment.

Thyssenkrupp (DE:) plans to keep a majority in the business – which is being rebranded as Thyssenkrupp Nucera – following any IPO and aims to maintain the current shareholding ratio with its Italian co-owner De Nora, said Volkmar Dinstuhl, who leads the conglomerate’s Multi Tracks division.

This implies a free-float of up to 25%.

The 500 million-600 million in potential proceeds would correspond to a stake sale of roughly 10-20% based on a valuation range of 3 billion to 6 billion euros that analysts have put on the division, which could be listed in the spring.

Thyssenkrupp Nucera is the world’s top supplier of chlor-alkali membrane technologies needed to produce hydrogen, competing with Japan’s Asahi Kasei, China’s Bluestar Beijing Chemical Machinery and Britain’s chemicals group Ineos.

It is also active in alkaline water electrolysis, a key requirement for the generation of hydrogen produced via renewable energy, pitting it against Norway’s Nel ASA, UK’s ITM Power and France’s McPhy Energy SAS.

“Demand is huge. We want to use that opportunity,” Denis Krude, CEO of Thyssenkrupp Nucera, told Reuters ahead of a capital markets on Thursday where investors are getting more detail on the business for the first time.

“We are a technology leader for electrolysis and have been in the business for decades,” Krude, who has led the division since October 2016, said.

In the fiscal year that ended in September, Thyssenkrupp Nucera posted earnings before interest and tax of 27 million euros while sales came in at 319 million euros, a level expected to triple to 900 million to 1 billion euros by 2025/26.

The potential proceeds from selling new shares do not factor in the sale of existing stakes by current owners Thyssenkrupp and De Nora, which own Thyssenkrupp Nucera in a 66/34 split.

Thyssenkrupp, which first floated the idea of an IPO of its hydrogen business in May last year, declined to say how much it would sell as part of a secondary offering in case of an IPO.

“The market has enormous potential,” Krude said, adding Nucera would invest 200 million to 300 million by 2024/25, of which 150 million-200 million will be spent on strategic moves including partnerships, production and smaller deals.

Europe, most notably Germany, wants to be a world leader in green hydrogen, which is generated via renewable sources and is carbon-neutral, to cut emissions and decarbonise its economy.

Thyssenkrupp, which makes everything from steel and submarines to car parts and fertiliser plants, sees an IPO as the preferred option for Nucera but has not made a final decision.

“For the Thyssenkrupp group the most important thing in a possible IPO is the so-called value crystallisation,” said Dinstuhl.

($1 = 0.8738 euro)

Related Articles

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button